Trials / Completed
CompletedNCT05477147
Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Volta Medical · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Multi-center, international, non-randomized clinical trial evaluating the use of Volta's VX1 algorithm as used in combination with repeat catheter ablation after AF recurrence after previous catheter ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Catheter Ablation | Cardiac catheter ablation for recurrent AF after previous ablation (catheter or surgical). |
Timeline
- Start date
- 2023-03-17
- Primary completion
- 2025-05-07
- Completion
- 2025-09-30
- First posted
- 2022-07-28
- Last updated
- 2025-12-09
Locations
19 sites across 4 countries: United States, Belgium, France, Germany
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05477147. Inclusion in this directory is not an endorsement.